# Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

> **NCT01239719** · PHASE3 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 96 (estimated)

## Conditions studied

- Allergy
- Dermatitis

## Interventions

- **DRUG:** Dexamethasone + clemastine
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01239719
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-12
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2011-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239719, "Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01239719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*